FDA approves Protalix's (PLX) Gaucher Disease drug Elelyso
Tweet Send to a Friend
Up)
The FDA approved Protalix's (NYSE: PLX) Gaucher Disease drug Elelyso
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Novo Nordisk (NVO) Reports Positive Results from Paradigm 2
- Mylan (MYL) Launches Generic Tricor Tabs (ABBV)
- SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed Accounting
Create E-mail Alert Related Categories
FDA, Hot FDA News
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
